LATEST NEWS

Domo Salute at the 26th edition of Hospitalar Trade Fair

Date: 06/05/2019

For the third consecutive year, Domo Salute has participated in the most relevant Latin American showcase in the health sector: Hospitalar Trade Fair. At Rio Grande do Sul’s collective stand, which was organized by Sebrae RS, Health Technology Cluster and the State Government, companies had the opportunity to advertise their products and services during the four days of the event, that is, from May 21st to May 24th, 2019.

In its 26th edition, the fair provided business opportunities, as well as new contacts, relationship strengthening, visibility, brand positioning support, and hosted several lectures and events promoted by major organizations and companies of the sector. Among the events that take place concurrently with the fair, the 10th Industrial Political Action and Medical Devices Regulation Day stands out. It is promoted by ABIMO and traditionally features numerous lectures presented by representatives of ANVISA and other regulatory bodies, among them INMETRO. Domo Salute’s regulatory specialist team was present at the event and kept a watchful eye on the new updates in the area.

Part of the event’s agenda included Sebrae Panel: Health in Brazil – Trends and Opportunities, which Domo Salute was privileged to be part of. On this occasion, Domo Salute gave lectures on three days, addressing the following subjects: “The Main Regulatory Challenges for European Medical Devices Registration” and “Current Issues Regarding Medical Devices Registration before ANVISA”.
Domo Salute’s regulatory manager and also a lecturer during the event, Amanda Frasson, observes, “Hospitalar is already a big event our company’s calendar and, as in previous years, its results have been very significant. Partnership strengthening, new business prospecting and further consolidation of our brand name in the market are some of the benefits Hospitalar provides us. Moreover, having the opportunity to speak in the biggest fair of the sector in Latin America has undoubtedly been a great achievement for our company.”

Diego Louzada, business developer in the company, also highlights the importance of the fair: “We are pleased and thrilled to have once again been part of Hospitalar, a mandatory event in Domo Salute’s calendar. This year we had the opportunity to speak during the fair for the first time, and we kicked off with three lectures. Meeting our customers and partners, being alert to innovations in our market, as well as prospecting new possibilities sort of outline our day-to-day in the fair. Our participation was very substantial and we already look forward to Hospitalar 2020, an event which will be held at a new venue.

MORE NEWS

07/18/2024
  From June 24 to 28, ANVISA participated in the MDSAP Forum and Regulatory Authority Council (RAC) meeting in Essen, Germany. The event gathered representatives from 27 countries, including regulatory authorities, MDSAP auditing organizations, and industry representatives, with notable attendance from Brazilian associations ABIMED and [...]
07/02/2024
  In force since January 2022, RDC 591/2021, which provides for the Unique Device Identification (UDI) system, was amended by ANVISA just days before the deadline for attributing and affixing UDI to risk class IV devices. The amendment was published in RDC 884/2024 on June 1, 2024, and is already in force. According to ANVISA,... Leia [...]
04/12/2024
Marking a significant advancement in regulatory reliance mechanisms, the National Health Surveillance Agency (ANVISA) published Normative Instruction (IN) 290/2024, on April 8, 2024. This normative introduces an optimized procedure for evaluating and deciding on registration petitions for medical devices previously regulated in recognized [...]
03/22/2024
Important Regulatory Update for Manufacturers under MDSAP in Brazil Today, ANVISA has announced a significant regulatory development with the publication of Resolution RDC 850/2024. This regulation brings forth a crucial amendment concerning the validity period of the Brazilian Good Manufacturing Practices (BGMP) Certificate for manufacturers [...]
01/05/2024
Collegiate Board Resolution (RDC) 837/2023, published by ANVISA on December 15th, 2023, brings updates to the rules regarding clinical investigations with medical devices performed in Brazil. Effective immediately from the publication, this resolution aligns Brazilian practices with international standards, providing clearer guidelines for [...]
12/13/2023
On 11 of December 2023, ANVISA published Collegiate Board Resolution – RDC 830/2023, addressing risk classification, registration procedures, as well as labeling requirements and instructions for use of in vitro diagnostic medical devices (IVDs) in Brazil. The new RDC, effective from June 1, 2024, is a comprehensive revision that consolidates [...]
11/28/2023
Public Consultation No. 1.208 will be open to receive contributions until December 9th. In the dynamic landscape of medical device regulations in Brazil, obtaining the Brazilian Good Manufacturing Practices (BGMP) certification is a mandatory request for manufacturers of Class III and Class IV devices seeking Registro. In a recent move towards [...]
03/01/2023
  Starting today – March 1st 2023 – the new Resolution RDC nº 751/2022  comes into force. The Resolution provides for risk classification, Notification and Registro processes, and the requirements for medical devices’ labeling and instructions for use. In order to meet the new requirements and procedures, ANVISA has already [...]
09/22/2022
The Collegiate Board Resolution – RDC 751/2022 was published on the 21st of September 2022, which provides for risk classification, Notification and Registro processes, and the requirements for medical devices’ labeling and instructions for use. The new RDC consolidates the risk classification and regularization regimes for all risk [...]